Related Experiment Video
Updated: May 15, 2026

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
[Anesthetic malignant hyperthermia: what's new in 2012?]
Y Nivoche1, B Bruneau, S Dahmani
1Département d'anesthésiologie et réanimation, hôpital Robert-Debré, AP-HP, 48, boulevard Sérurier, 75019 Paris, France. ynivoche.debre@invivo.edu
Abstract:
Malignant hyperthermia (MH) is a pharmacogenetic disorder of anesthesia. Recent advances dealing with epidemiology of MH and the safe anesthetic course of MH susceptible patients are shortly presented here with a special insight into the preparation of modern anesthesia workstations, which they will share in operating room.
Related Concept Videos
Inhalational Anesthetics: Overview
Skeletal Muscle Relaxants: Therapeutic Uses
Increased Body Temperature
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
